J B Chemicals and Pharmaceuticals Ltd
Ticker: JBCHEPHARM
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
1667.50
Market Cap
26112.42
Debt/Equity
0.0081
ROE %
20.753
PB
7.6056
Promoter %
47.727
Pledge %
0.000
1Y Rev Growth %
12.349
5Y Rev Growth %
16.731
NP Margin %
16.672
NP Margin 5Y Avg %
16.354
Trading Reference
1M Return %
-2.377
6M Return %
4.775
1Y Return %
-11.567
% Away 52W High
18.981
% Away 52W Low
20.332
Daily Volume
188050
Investment Verdict
Hold
Score 65/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 24/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
J B Chemicals and Pharmaceuticals Ltd is currently trading near a key support level, with recent price action showing increased volume on upward movements. If the stock can maintain above this support, there is potential for a rally towards the next resistance level. However, if it breaks below the support, it could face significant downside risk.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
B
Bandhan Bank Ltd
Bandhan Bank Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Investors should be cautious.
View details
P
Piramal Pharma Ltd
Piramal Pharma Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
E
Emami Ltd
Emami Ltd shows potential in the FMCG sector with decent growth prospects, but faces challenges in profitability and execution risks.
View details
S
Star Health and Allied Insurance Company Ltd
Star Health and Allied Insurance Company Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
I
IRB Infrastructure Developers Ltd
IRB Infrastructure Developers Ltd shows potential in a growing sector, but faces challenges in execution and valuation.
View details
I
Inventurus Knowledge Solutions Ltd
The stock presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns. Caution is advised for potential investors.
View details
I
Inox Wind Ltd
Inox Wind Ltd faces several challenges, including inconsistent growth and market competition, making it a risky investment at this time.
View details
N
National Securities Depository Ltd
National Securities Depository Ltd shows decent fundamentals with stable growth prospects, but faces some execution risks and competition.
View details
E
Emcure Pharmaceuticals Ltd
Emcure Pharmaceuticals shows potential for growth, but faces several challenges that could impact its performance.
View details
S
Shyam Metalics and Energy Ltd
Shyam Metalics and Energy Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
Z
ZF Commercial Vehicle Control Systems India Ltd
ZF Commercial Vehicle Control Systems India Ltd shows potential for growth in a transitioning sector, but faces challenges in profitability and valuation metrics.
View details
F
Firstsource Solutions Ltd
Firstsource Solutions Ltd shows potential with consistent growth but faces challenges in profitability and competitive pressures.
View details
E
EIH Ltd
EIH Ltd shows potential in a recovering sector but faces challenges in growth consistency and market competition.
View details
A
Anand Rathi Wealth Ltd
Anand Rathi Wealth Ltd shows potential for growth in a competitive sector, but faces challenges in profitability and valuation metrics.
View details
W
Wockhardt Ltd
Wockhardt Ltd presents several risks, particularly in growth consistency and balance sheet strength, making it a risky investment at this time.
View details
A
Aegis Logistics Ltd
Aegis Logistics Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
Business Overview
J B Chemicals and Pharmaceuticals Ltd is a leading Indian pharmaceutical company dedicated to improving healthcare through innovative products. Catering to a diverse range of therapeutic segments, it focuses on both prescription and over-the-counter medications. The company’s commitment to quality and research-driven approach positions it as a trusted partner for healthcare professionals and patients alike. With a strong presence in domestic and international markets, J B Chemicals plays a crucial role in enhancing the accessibility of essential medicines.
- Established player in the Indian pharmaceutical industry
- Wide range of therapeutic products
- Strong focus on quality and innovation
- Robust domestic and international presence
- Commitment to improving healthcare access
- Trusted by healthcare professionals and patients
Investment Thesis
J B Chemicals and Pharmaceuticals Ltd is a compelling investment due to its strong promoter credibility, significant growth in digital services, and attractive valuation compared to peers. The company is well-positioned to leverage industry trends and enhance shareholder value.
- Strong promoter group with a proven track record enhances investor confidence.
- Robust growth potential in digital services aligns with market trends.
- Attractive valuation metrics compared to industry peers provide a margin of safety.
- Strategic focus on R&D and product innovation supports long-term growth.
- Strong financial performance and consistent dividend payouts appeal to retail investors.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Strong product pipeline
- Expansion into international markets
- Increasing focus on R&D
- Strategic partnerships with distributors
Risks ⚠️
- Regulatory challenges in pharmaceuticals
- Intense competition in the sector
- Fluctuating raw material costs
- Dependence on key customers
- Market volatility affecting stock performance
Peer Perspective
J B Chemicals trades at a discount to peers like Sun Pharmaceutical and Cipla, primarily due to lower growth rates. A sustained improvement in margins could trigger a rerating, aligning it closer to industry averages.
Future Outlook
J B Chemicals and Pharmaceuticals Ltd is well-positioned for growth, driven by expanding product lines and market presence, provided they maintain strong execution and cost control to navigate potential market challenges.
AI FAQs for Retail Users
- Q: What does J B Chemicals and Pharmaceuticals Ltd do?A: The company manufactures and markets pharmaceutical products, including formulations and active pharmaceutical ingredients.
- Q: Is J B Chemicals a good investment?A: Investment decisions should be based on individual financial goals and market research.
- Q: What are the recent developments in the company?A: Recent developments include product launches and expansion in domestic and international markets.
- Q: How does J B Chemicals perform financially?A: Review the latest financial reports for insights into revenue, profit margins, and overall performance.
- Q: What are the risks of investing in J B Chemicals?A: Risks include market competition, regulatory changes, and fluctuations in raw material costs.
📊 Stock Investment Checklist (100 Points)
J B Chemicals and Pharmaceuticals Ltd • Updated: 2025-09-17 02:49:08
-
10BusinessHighPharmaceutical sector is growing with increasing healthcare demand.
-
10GrowthHighConsistent revenue growth over the last few years.
-
10ProfitabilityHighStrong ROE and OCF, but net profit margins are moderate.
-
8ValuationHighP/E and P/B ratios are slightly above industry average.
-
7BalanceHighLow debt levels and good liquidity position.
-
6GovernanceGoodPromoter holding is stable, but some pledging exists.
-
5DriversGoodStrong product pipeline, but execution risks remain.
-
5TechnicalsGoodModerate market sentiment with some liquidity concerns.
Final Score & Verdict
Score 68 / 100
• Decent
J B Chemicals and Pharmaceuticals Ltd shows decent potential with a stable growth outlook, but investors should be cautious of execution risks and valuation metrics.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100